We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
5
1 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Active, not recruiting
1
20.0%
Completed
2
40.0%
Temporarily Not Available
Terminated
No approval data available
- ProKidney focuses on its US-based Phase 3 trial of rilparencel for type 2 diabetes and chronic kidney disease, discontinuing a trial in Spain. - Amarna Therapeutics receives FDA guidance on its AM510 gene therapy for type 1 diabetes, aiming for tolerance induction. - Vertex's VX-880 continues to show potential in reducing or eliminating the need for insulin in type 1 diabetes patients. - PolarityTE screens first patient for SkinTE pivotal trial for diabetic foot ulcers, addressing a critical complication of diabetes.
